Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In published preclinical research, Epithalon has been administered across rodent, fly, and cell-culture model systems with intraperitoneal, subcutaneous, and intranasal routes characterised across the literature (PMID 11087911, PMID 17955380, PMID 35413689)
This action minimizes the shift to less efficient anaerobic respiration, preserving cellular energy and reducing oxidative damage ( 9 )
GLP-1 Receptor Activation: Suppresses appetite through hypothalamic pathways Slows gastric emptying Enhances insulin secretion GIP Receptor Activation: Amplifies GLP-1 satiety effects Improves insulin sensitivity May directly affect fat cell metabolism Glucagon Receptor Activation: Increases energy expenditure (metabolic rate) Promotes fat breakdown (lipolysis) May prevent metabolic adaptation The Advantage: Single molecule means simpler manufacturing, potentially easier regulatory approval, and all three pathways activated with every dose
US$ 29.42
US$ 26.17
US$ 25.75
US$ 22.90
US$ 23.67
.jpg)
US$ 22.86
US$ 22.14
US$ 27.10
US$ 27.70
